Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Meeting Report
  • Published:

Targeted protein degradation

Proximity-inducing pharmacology

Nature Chemical Biology volume 20, pages 13–14 (2024)Cite this article

Controlled interactions between macromolecules are fundamental regulatory layers. Hijacking these circuits via proximity-inducing small molecules offers many therapeutic opportunities. The organizers, Georg Winter and Cristina Mayor-Ruiz, report on the latest trends in this emerging field discussed at the 39th IRB-BioMed Conference in Barcelona.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Attendees at the 39th IRB-BioMed Conference,“Proximity-inducing pharmacology: targeted protein degradation and beyond,” held in Barcelona on 22–25 May 2023.

References

  1. Kofink, C. et al. Nat. Commun. 13, 5969 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Tsai, J. M. et al. Mol. Cell 83, 2753–2767 e10 (2023).

    Article  CAS  PubMed  Google Scholar 

  3. Hsia, O. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.02.14.528511 (2023).

  4. Ahn, G. et al. Science 382, eadf6249 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hoi, D. M. et al. Cell 186, 2176–2192 e22 (2023).

    Article  CAS  PubMed  Google Scholar 

  6. Morreale, F. E. et al. Cell 185, 2338–2353 e18 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Raina, K. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.01.01.522436 (2023).

  8. Tong, Y. et al. Nature 618, 169–179 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Szulc, N. A. et al. Preprint at bioRxiv https://doi.org/10.1101/2022.05.19.492622 (2022).

Download references

Author information

Authors and Affiliations

  1. Research Center for Molecular Medicine (CeMM), Austrian Academy of Sciences, Vienna, Austria

    Georg E. Winter

  2. Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Technology (BIST), Barcelona, Spain

    Cristina Mayor-Ruiz

Authors
  1. Georg E. Winter
    View author publications

    Search author on:PubMed Google Scholar

  2. Cristina Mayor-Ruiz
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Georg E. Winter or Cristina Mayor-Ruiz.

Ethics declarations

Competing interests

G.E.W. is a scientific founder and shareholder of Proxygen and Solgate. His lab has received research funding from Pfizer. C.M.-R. is part of the scientific advisory board of Nostrum Biodiscovery. Her lab has received or receives sponsored research support from Almirall and Aelin Tx.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Winter, G.E., Mayor-Ruiz, C. Proximity-inducing pharmacology. Nat Chem Biol 20, 13–14 (2024). https://doi.org/10.1038/s41589-023-01492-2

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41589-023-01492-2

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing